- MSc, Radiation Biophysics, Norwegian University of Science and Technology
- PhD, Biophysics, University of Oslo
Tumor hypoxia (poor oxygenation) limits efficacy of radio- and chemotherapy and promotes a more malignant phenotype. Our aim is to identify novel treatment strategies to mitigate the adverse effects of tumor hypoxia. To this end, we are exploiting pharmaceutical agents that affect the tumor microenvironment. We also aim to better understand how hypoxia regulates signaling and gene expression that confers altered metabolism, cancer cell survival and metastasis. See also www.wklab.org.
Associate Professor, Department of Radiation Oncology, University of Toronto
Scientific Associate, Ontario Cancer Institute
Full Member, Institute of Medical Science, University of Toronto